SCHUH ANTONIUS 4
4 · TrovaGene Inc. · Filed Nov 6, 2012
Insider Transaction Report
Form 4
TrovaGene Inc.TROV
SCHUH ANTONIUS
DirectorCEO
Transactions
- Award
Stock Options
2012-10-15+200,000→ 833,333 totalExercise: $4.06Exp: 2022-10-15→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The options vest in the event that the Company (i) launches a K-RAS CLIA test in the first quarter of 2013 and (ii) generates a minimum of aggregate sales of $500,000 from a K-RAS or BRAF CLIA test by August 1, 2013, provided the Optionee on the vesting date continues to provide Service to a Participating Company Group.